Keywords: IVIM, Radiomics, IVIM, MRI, habitats, breast tumor, estrogen receptor
Motivation: Immunohistochemistry remains the gold standard for diagnosing the estrogen receptor (ER) factor in breast cancer. However, the non-invasive IVIM radiomics method offers a meaningful alternative for predicting ER expression.
Goal(s): The objective of this study is to assess the feasibility and performance of a prediction model based on tumors habitats in predicting ER expression in malignant breast cancer patients.
Approach: We developed and evaluated a predictive model that utilizes tumors habitats to diagnose ER expression.
Results: The IVIM indicators can be employed for tumor subregions’ segmentation to hypoxia. The model demonstrates effective prediction capabilities for determining the probability of ER-positive in breast cancer.
Impact: Our research highlights the excellent performance of the predictive model based on tumors habitats in predicting ER expression in breast cancer. The model can aid clinicians in making more informed treatment decisions and subsequently improve patient outcomes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords